相关实验视频
Updated: Jun 24, 2025

03:37
Self-Administration of Drugs in Mouse Models of Feeding and Obesity
Published on: June 8, 2021
4.5K
在精神分裂症中GLP-1受体激动剂和减肥 - - 过去,现在和未来
Mike Trott1,2,3, Urska Arnautovska1,2,3, Dan Siskind1,2,3
1Faculty of Medicine, The University of Queensland, Brisbane.
Current opinion in psychiatry
|June 7, 2024
概括
类似葡萄糖-1受体激动剂 (GLP-RAs) 在精神分裂症患者中显示出减肥的潜力,尽管效果可能比一般人群小. 未来的研究应该探索双重/三重激动剂和早期干预,以防止体重增加.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 精神病学药理疗法精神病学药理疗法
- 临床试验分析临床试验分析
背景情况:
- 精神分裂症患者面临更高的肥胖和糖尿病风险,影响生活质量和治疗坚持.
- 目前用于抗精神病药物诱导的体重增加的治疗方法是不够的.
- 类似葡萄糖-1受体激动剂 (GLP-RAs) 在一般人群中有效减肥,但它们在精神分裂症中的有效性需要进一步研究.
研究的目的:
- 对GLP-RAs用于精神分裂症体重管理的已完成和正在进行的临床试验进行审查.
- 为了确定潜在的未来的研究方向,在这个人群中治疗肥胖.
主要方法:
- 完成的临床试验的系统审查.
- 分析正在进行和计划的临床试验.
- 对精神分裂症与普通人群的影响大小的评估.
主要成果:
- 已经完成了六项临床试验,其中四项已发表.
- 目前,另外三项试验正在进行中.
- 在精神分裂症患者中,GLP-RAs表现出减肥效果,尽管效果大小通常小于一般人群中观察到的效果.
结论:
- 在精神分裂症患者中,GLP-RA对体重管理有前途.
- 未来的研究应该调查双重或三重激动剂.
- 在抗精神病治疗开始时探索GLP-RAs的使用可能有助于预防体重增加.
相关概念视频
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Oral Hypoglycemic Agents: Glinides
152
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
152
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
Regulation of Food Intake
220
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
220

